[Eye controlled speech generating device]

Donato M, Augustovski F, Alfie V, Argento F, García Martí S, Ciapponi A, Bardach A, Alcaraz A, Pichon Riviere A
Record ID 32018002320
Original Title: Dispositivos generadores de voz controlados con la mirada
Authors' recommendations: No studies comparing the different types of eye controlled speech-generating device, or operated in any other form have been found. No studies comparing its use against standard of care have been found either. Low-quality evidence from case series studies suggest that using eye controlled speech-generating devices would improve some aspects of communication of the individuals with complex motor and speech disabilities (such as cerebral palsy, amyotrophic lateral sclerosis and Rett syndrome). These improvements were evidenced when compared to baseline, at six-month follow up, in the setting of rehabilitation centers with a specialized multidisciplinary treatment team. Similar results were reported by families and caregivers. Most of the studies reported a high rate of acceptance of the technology, although they identified difficulties to establish communication with people with epilepsy episodes and tremor. Difficulties such as discomfort, tiredness and boredom of the users were also reported. The clinical practice guidelines surveyed determine that alternative and augmentative communication, where the eye controlled speech-generating devices are mentioned, is necessary for those patients with language and speech disabilities. These devices are not explicitly mentioned in the Mandatory Medical Program, the Unique Reimbursement System of the Superintendence of Health Services of Argentina, or any other coverage policy of the Latin American countries surveyed. Among the coverage policies of the high-income countries surveyed, only the United States and the United Kingdom mention eye controlled speech generating devices for the assessed indications. No economic studies (neither for Argentina or any other country) were found, therefore its cost-effectiveness or budget impact is uncertain.
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Speech
  • Communication Aids for Disabled
  • Speech Disorders
  • Self-Help Devices
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.